Qais Mekki

2.6k total citations
28 papers, 2.3k citations indexed

About

Qais Mekki is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Qais Mekki has authored 28 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Surgery and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Qais Mekki's work include Diabetes Treatment and Management (13 papers), Renal Transplantation Outcomes and Treatments (10 papers) and Pharmacological Effects and Toxicity Studies (9 papers). Qais Mekki is often cited by papers focused on Diabetes Treatment and Management (13 papers), Renal Transplantation Outcomes and Treatments (10 papers) and Pharmacological Effects and Toxicity Studies (9 papers). Qais Mekki collaborates with scholars based in United States, Japan and Germany. Qais Mekki's co-authors include P. Fleck, Dawna Dressler, Ihor Bekersky, Craig Wilson, Richard E. Pratley, Carol Wilson, Mary F. Hébert, Julio Rosenstock, Elisabeth R. Wann and Aziz Karim and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Qais Mekki

28 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qais Mekki United States 21 1.3k 691 671 561 517 28 2.3k
Darlene Barr United States 16 139 0.1× 346 0.5× 547 0.8× 300 0.5× 169 0.3× 33 1.6k
Peter Kuehl United States 6 206 0.2× 180 0.3× 1.0k 1.5× 487 0.9× 420 0.8× 8 2.4k
Renzo Wolbold Germany 8 232 0.2× 128 0.2× 763 1.1× 274 0.5× 248 0.5× 9 1.8k
Damayanthi Devineni United States 21 1.1k 0.8× 730 1.1× 163 0.2× 476 0.8× 24 0.0× 35 1.5k
Kimberly L. Napoli United States 25 68 0.1× 617 0.9× 275 0.4× 434 0.8× 1.3k 2.5× 56 2.1k
Barry Gumbiner United States 25 1.1k 0.9× 1.3k 1.9× 111 0.2× 597 1.1× 17 0.0× 51 2.7k
Stephen D. Zucker United States 26 145 0.1× 260 0.4× 362 0.5× 1.2k 2.2× 31 0.1× 60 2.3k
Michiko Kawamoto United States 17 79 0.1× 151 0.2× 1.1k 1.6× 451 0.8× 82 0.2× 27 1.7k
Richard A. Castro United States 15 344 0.3× 301 0.4× 752 1.1× 636 1.1× 12 0.0× 16 1.6k
Lina Quteineh Switzerland 10 361 0.3× 533 0.8× 114 0.2× 70 0.1× 140 0.3× 20 1.5k

Countries citing papers authored by Qais Mekki

Since Specialization
Citations

This map shows the geographic impact of Qais Mekki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qais Mekki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qais Mekki more than expected).

Fields of papers citing papers by Qais Mekki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qais Mekki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qais Mekki. The network helps show where Qais Mekki may publish in the future.

Co-authorship network of co-authors of Qais Mekki

This figure shows the co-authorship network connecting the top 25 collaborators of Qais Mekki. A scholar is included among the top collaborators of Qais Mekki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qais Mekki. Qais Mekki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
DeFronzo, Ralph A., Charles Burant, P. Fleck, et al.. (2012). Efficacy and Tolerability of the DPP-4 Inhibitor Alogliptin Combined with Pioglitazone, in Metformin-Treated Patients with Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 97(5). 1615–1622. 87 indexed citations
2.
Rosenstock, Julio, Silvio E. Inzucchi, Jochen Seufert, et al.. (2010). Initial Combination Therapy With Alogliptin and Pioglitazone in Drug-Naïve Patients With Type 2 Diabetes. Diabetes Care. 33(11). 2406–2408. 102 indexed citations
3.
Karim, Aziz, Aziz Laurent, Melvin Munsaka, et al.. (2009). Coadministration of Pioglitazone or Glyburide and Alogliptin: Pharmacokinetic Drug Interaction Assessment in Healthy Participants. The Journal of Clinical Pharmacology. 49(10). 1210–1219. 34 indexed citations
4.
Rosenstock, Julio, Marc Rendell, Jorge Luiz Gross, et al.. (2009). Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA 1c without causing weight gain or increased hypoglycaemia. Diabetes Obesity and Metabolism. 11(12). 1145–1152. 170 indexed citations
5.
Pratley, Richard E., et al.. (2008). Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy. Diabetes Obesity and Metabolism. 11(2). 167–176. 143 indexed citations
6.
7.
8.
Christopher, Ronald, Paul S. Covington, Miles P. Davenport, et al.. (2008). Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects. Clinical Therapeutics. 30(3). 513–527. 106 indexed citations
9.
Yocum, David E., Daniel E. Fürst, Jeffrey Kaine, et al.. (2003). Efficacy and safety of tacrolimus in patients with rheumatoid arthritis: A double‐blind trial. Arthritis & Rheumatism. 48(12). 3328–3337. 84 indexed citations
10.
Bekersky, Ihor, Dawna Dressler, & Qais Mekki. (2001). Effect of Time of Meal Consumption on Bioavailability of a Single Oral 5 mg Tacrolimus Dose. The Journal of Clinical Pharmacology. 41(3). 289–297. 72 indexed citations
11.
Bekersky, Ihor, Dawna Dressler, & Qais Mekki. (2001). Effect of Low‐ and High‐Fat Meals on Tacrolimus Absorption following 5 mg Single Oral Doses to Healthy Human Subjects. The Journal of Clinical Pharmacology. 41(2). 176–182. 106 indexed citations
12.
Bekersky, Ihor, et al.. (2001). Comparative Tacrolimus Pharmacokinetics: Normal versus Mildly Hepatically Impaired Subjects. The Journal of Clinical Pharmacology. 41(6). 628–635. 39 indexed citations
13.
Pirsch, John D., Ihor Bekersky, Flavio Vincenti, et al.. (2000). Coadministration of Tacrolimus and Mycophenolate Mofetil in Stable Kidney Transplant Patients: Pharmacokinetics and Tolerability. The Journal of Clinical Pharmacology. 40(5). 527–532. 32 indexed citations
14.
Bekersky, Ihor, Dawna Dressler, & Qais Mekki. (1999). Dose linearity after oral administration of tacrolimus 1-mg capsules at doses of 3, 7, and 10 mg. Clinical Therapeutics. 21(12). 2058–2064. 16 indexed citations
15.
Bekersky, Ihor, Dawna Dressler, Wayne A. Colburn, & Qais Mekki. (1999). Bioequivalence of 1 and 5 mg Tacrolimus Capsules Using a Replicate Study Design. The Journal of Clinical Pharmacology. 39(10). 1032–1037. 16 indexed citations
16.
Bekersky, I, et al.. (1998). Demographic Considerations in Tacrolimus Pharmacokinetics. Transplantation Proceedings. 30(4). 1359–1364. 49 indexed citations
17.
Bekersky, I, et al.. (1998). Bioequivalence of a New Strength Tacrolimus Capsule Under Development. Transplantation Proceedings. 30(4). 1457–1459. 7 indexed citations
18.
Boswell, Garry, Ihor Bekersky, Qais Mekki, & James C. Eisenach. (1997). Plasma concentrations and disposition of clonidine following a constant 14-day epidural infusion in cancer patients. Clinical Therapeutics. 19(5). 1024–1030. 7 indexed citations
19.
Floren, Leslie Carstensen, Ihor Bekersky, Leslie Z. Benet, et al.. (1997). Tacrolimus oral bioavailability doubles with coadministration of ketoconazole*. Clinical Pharmacology & Therapeutics. 62(1). 41–49. 220 indexed citations
20.
Jusko, William J., Wojciech Piekoszewski, Göran B. Klintmalm, et al.. (1995). Pharmacokinetics of tacrolimus in liver transplant patients*. Clinical Pharmacology & Therapeutics. 57(3). 281–290. 204 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Darlene Barr Breakdown of academic impact, for papers by Peter Kuehl Breakdown of academic impact, for papers by Renzo Wolbold Breakdown of academic impact, for papers by Damayanthi Devineni Breakdown of academic impact, for papers by Kimberly L. Napoli Breakdown of academic impact, for papers by Barry Gumbiner Breakdown of academic impact, for papers by Stephen D. Zucker Breakdown of academic impact, for papers by Michiko Kawamoto Breakdown of academic impact, for papers by Richard A. Castro Breakdown of academic impact, for papers by Lina Quteineh
Rankless by CCL
2026